Interactive Investor
>>

Nuformix (LSE:NFX) Share Price

NFX

Nuformix

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Nuformix PLC is a pharmaceutical development company. It is focused on building value for shareholders through its activities in drug development and by out-licensing. The company uses cocrystal technology to re-engineer the crystalline form of known small molecule drugs. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.

LSE:NFX

GB00BYW79Y38

GBX

Loading...

Loading Comparison

Latest NFX News

NFX Regulatory News